Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
|
Revenue
¥8.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue?
Revenue
8.2B
CNY
Based on the financial report for Dec 31, 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue amounts to 8.2B CNY.
What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Revenue growth rate?
Revenue CAGR 10Y
3%
Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd have been 8% over the past three years , 5% over the past five years , and 3% over the past ten years .